PL-18: Predictive factors of success after gastric banding: A nationwide survey on the role of patients' behavior and center activity

Chevallier, Jean‐Marc; Païta, Michel; Marty, M.; Slim, K.; Basdevant, Arnaud

doi:10.1016/j.soard.2008.03.058

Cited by 48 publications

(86 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…All six studies 27,28,30,36,38,39 examining surgical sequelae demonstrated increases in complications with lower surgeon volumes, including the three studies that reported adjusted results (Table 3).…”

Section: Association Between Facility-level or Surgeonlevel Surgmentioning

confidence: 99%

“…Description of Included Studies. Of 973 citations, 14 articles met inclusion criteria and examined the relationship between hospital volume (10 studies) [26][27][28][29][30][31][32][33][34][35] , surgeon volume (eight studies) 27,28,30,34,[36][37][38][39] ,and outcomes; four studies 27,28,30,34 examined two of these relationships. Study sample sizes ranged from 150 to 102,069 patients.…”

Section: Association Between Facility-level or Surgeonlevel Surgmentioning

confidence: 99%

See 1 more Smart Citation

Bariatric Surgery: A Systematic Review of the Clinical and Economic Evidence

et al. 2011

View full text Add to dashboard Cite

Section: Association Between Facility-level or Surgeonlevel Surgmentioning

confidence: 99%

Section: Association Between Facility-level or Surgeonlevel Surgmentioning

confidence: 99%

Bariatric Surgery: A Systematic Review of the Clinical and Economic Evidence

et al. 2011

View full text Add to dashboard Cite

“…Jos efektyvumas patvirtintas daugelyje studijų, tačiau ne visiems ligoniams pasiekiamas norimas gydymo rezultatas [4][5][6]. Radome tik pavienių studijų, kuriose nagrinėta priešoperacinių veiksnių įtaka prognozuojant kūno masės mažėjimą po SARJO [7][8][9][10][11][12]. Šio darbo tikslas -priešoperacinių veiksnių, leidžiančių prognozuoti perteklinės kūno masės sumažėjimą, paieška.…”

Section: įVadasunclassified

Priešoperacinių veiksnių įtaka prognozuojant kūno masės sumažėjimą praėjus penkeriems metams po nutukimo gydymo skrandžio apjuosimo reguliuojama juosta operacijos: perspektyvusis atsitiktinių imčių tyrimas

Juodeikis¹,

Brimas²

2017

View full text Add to dashboard Cite

Priešoperacinių veiksnių įtaka prognozuojant kūno masės sumažėjimą praėjus penkeriems metams po nutukimo gydymo skrandžio apjuosimo reguliuojama juosta operacijos: perspektyvusis atsitiktinių imčių tyrimas BackgroundLaparoscopic adjustable gastric banding (LAGB) is used as a bariatric procedure for more than 30 years, but there is still insuf ficient data regarding postoperative weightloss predicting factors. ObjectiveWe carried out a prospective randomized study to compare two different bands (SAGB and Minimizer Extra) and aimed to find weightloss predicting factors. Methods A total of 103 morbidly obese patients underwent LAGB from January 2009 to January 2010. The SAGB was used in 49 and MiniMizer Extra in 54 patients. Weight loss was evaluated after 1 and 5 years. Factors which significantly correlated with per centage excess weight loss (%EWL) were used to build predicting regression models. ResultsThe mean patient age was 45.9 ± 11.7 years, and mean preoperative body mass index (BMI) was 47.5 ± 7.3 kg/m 2 . A total of 90 (87.3%) patients completed the 5year followup. The mean overall excess weight loss after 5 years was 47.3 ± 29.7%, and there was no difference between SAGB and MiniMizer bands (47.3% vs 50.3%; p = 0.14). After 1 year, BMI ≤ 47 MiniMizer, pa tients demonstrated better weight loss results. %EWL was also significantly greater in >40yearold MiniMizer group patients (p =0.012) and remained significantly higher after 5 years (p = 0.035). ConclusionsIn > 40yearold patient group better %EWL can be achieved by using MiniMizer Extra bands compared to SAGB. The con structed prognostic models could be used to predict %EWL after application of SAGB and MiniMizer bands.

show abstract

“…Indeed, the surgeon's and institution's experience, and patients'behaviour after surgery, are key determinants of its success or failure in all obese subjects, including those with T2DM [45].…”

Section: Prognostic Factorsmentioning

confidence: 99%

Bariatric surgery in patients with Type 2 diabetes: benefits, risks, indications and perspectives

Scheen

Flines

Roover³

et al. 2009

Diabetes & Metabolism

View full text Add to dashboard Cite

Obesity plays a key role in the pathophysiology of type 2 diabetes (T2DM), and weight loss is a major objective, although difficult to achieve with medical treatments. Bariatric surgery has proven its efficacy in obtaining marked and sustained weight loss, and is also associated with a significant improvement in glucose control and even diabetes remission. Roux-en-Y gastric bypass appears to be more effective in diabetic patients than the restrictive gastroplasty procedure. This may be explained not only by greater weight reduction, but also by specific hormonal changes. Indeed, increased levels of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) may lead to improved β-cell function and insulin secretion as well as reduced insulin resistance associated with weight loss. The presence of T2DM in obese individuals is a further argument to propose bariatric surgery, and even more so when diabetes is difficult to manage by medical means and other weight-related complications are present. Bariatric surgery is associated with a better cardiovascular prognosis and reduced mortality, even though acute and long-term complications may occur. The observation that surgical rerouting of nutrients triggers changes in the release of incretin hormones that, in turn, ameliorate the diabetic state in the absence of weight loss has led to the recent development of innovative surgical procedures. Thus, bariatric surgery may be said to be progressing towards so-called 'metabolic surgery', which merits further evaluation in patients with T2DM within a multidisciplinary approach that involves both surgeons and endocrinologists.Keywords : Bariatric surgery ; Gastric bypass ; Gastroplasty ; Obesity ; Type 2 diabetes ; Review RésuméChirurgie bariatrique chez les patients atteints de diabète de type 2: bénéfices, risques, indications et perspectives L'obésité joue un rôle-clé dans la physiopathologie du diabète de type 2 (DT2) et l'obtention d'une perte de poids est un objectif majeur, bien que difficile à atteindre avec les moyens médicaux. La chirurgie bariatrique a apporté la preuve de son efficacité pour induire un amaigrissement marqué et soutenu, qui s'accompagne d'une amélioration du contrôle glycémique et assez souvent d'une remission du diabète. La dérivation gastrique avec l'anse de Roux-en-Y apparaît être plus efficace chez les patients diabétiques que la simple technique restrictive qu'est la gastroplastie calibrée. Ceci peut s'expliquer non seulement par une perte pondérale supérieure, mais aussi par des modifications hormonales spécifiques. En effet, une augmentation des concentrations de GLP-1 (glucagon-like peptide-1) et de GIP (glucose-dependent insulinotropic polypeptide) avec la dérivation permet d'améliorer la fonction de la cellule β et la réponse insulinosécrétoire, en plus de la diminution de l'insulinorésistance consécutive à l'amaigrissement. La présence d'un DT2 chez un sujet obèse est un argument supplémentaire pour proposer une chirurgie bariatrique, d'autant plus qu...

show abstract

PL-18: Predictive factors of success after gastric banding: A nationwide survey on the role of patients' behavior and center activity

Cited by 48 publications

References 0 publications

Bariatric Surgery: A Systematic Review of the Clinical and Economic Evidence

Bariatric Surgery: A Systematic Review of the Clinical and Economic Evidence

Priešoperacinių veiksnių įtaka prognozuojant kūno masės sumažėjimą praėjus penkeriems metams po nutukimo gydymo skrandžio apjuosimo reguliuojama juosta operacijos: perspektyvusis atsitiktinių imčių tyrimas

Bariatric surgery in patients with Type 2 diabetes: benefits, risks, indications and perspectives

Contact Info

Product

Resources

About